Adial Pharmaceuticals Stock Probability of Future Stock Price Finishing Over 12.87
| ADIL Stock | USD 1.09 0.01 0.91% |
Adial |
Adial Pharmaceuticals Target Price Odds to finish over 12.87
The tendency of Adial Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 12.87 or more in 90 days |
| 1.09 | 90 days | 12.87 | close to zero percent |
Based on a normal probability distribution, the odds of Adial Pharmaceuticals to move over $ 12.87 or more in 90 days from now is close to zero percent (This Adial Pharmaceuticals probability density function shows the probability of Adial Stock to fall within a particular range of prices over 90 days) . Probability of Adial Pharmaceuticals price to stay between its current price of $ 1.09 and $ 12.87 at the end of the 90-day period is about 22.57 .
Given the investment horizon of 90 days Adial Pharmaceuticals has a beta of -0.36. This suggests as returns on the benchmark increase, returns on holding Adial Pharmaceuticals are expected to decrease at a much lower rate. During a bear market, however, Adial Pharmaceuticals is likely to outperform the market. Additionally Adial Pharmaceuticals has an alpha of 0.092, implying that it can generate a 0.092 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Adial Pharmaceuticals Price Density |
| Price |
Predictive Modules for Adial Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Adial Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Adial Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Adial Pharmaceuticals is not an exception. The market had few large corrections towards the Adial Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Adial Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Adial Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.09 | |
β | Beta against Dow Jones | -0.36 | |
σ | Overall volatility | 0.07 | |
Ir | Information ratio | -0.0027 |
Adial Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Adial Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Adial Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Adial Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Adial Pharmaceuticals had very high historical volatility over the last 90 days | |
| Adial Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (7 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Adial Pharmaceuticals currently holds about 9.16 M in cash with (6.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.35. | |
| Adial Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Latest headline from benzinga.com: EXCLUSIVE Adial Pharmaceuticals Lead Drug Secures Key US Patent For Alcohol Dependence Based on Expanded Genotype Combinations |
Adial Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Adial Stock often depends not only on the future outlook of the current and potential Adial Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Adial Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.4 M | |
| Cash And Short Term Investments | 2.8 M |
Adial Pharmaceuticals Technical Analysis
Adial Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Adial Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Adial Pharmaceuticals. In general, you should focus on analyzing Adial Stock price patterns and their correlations with different microeconomic environments and drivers.
Adial Pharmaceuticals Predictive Forecast Models
Adial Pharmaceuticals' time-series forecasting models is one of many Adial Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Adial Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Adial Pharmaceuticals
Checking the ongoing alerts about Adial Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Adial Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Adial Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Adial Pharmaceuticals had very high historical volatility over the last 90 days | |
| Adial Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (7 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Adial Pharmaceuticals currently holds about 9.16 M in cash with (6.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.35. | |
| Adial Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Latest headline from benzinga.com: EXCLUSIVE Adial Pharmaceuticals Lead Drug Secures Key US Patent For Alcohol Dependence Based on Expanded Genotype Combinations |
Check out Adial Pharmaceuticals Backtesting, Adial Pharmaceuticals Valuation, Adial Pharmaceuticals Correlation, Adial Pharmaceuticals Hype Analysis, Adial Pharmaceuticals Volatility, Adial Pharmaceuticals History as well as Adial Pharmaceuticals Performance. For more information on how to buy Adial Stock please use our How to buy in Adial Stock guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adial Pharmaceuticals. If investors know Adial will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adial Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.94) | Return On Assets (1.04) | Return On Equity (3.21) |
The market value of Adial Pharmaceuticals is measured differently than its book value, which is the value of Adial that is recorded on the company's balance sheet. Investors also form their own opinion of Adial Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Adial Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adial Pharmaceuticals' market value can be influenced by many factors that don't directly affect Adial Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adial Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adial Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adial Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.